Company intelligence / Profile preview

Prodeon Medical

Sunnyvale, California, United Statesprodeonmedical.com ↗

Ownership: Private
Development stage: Phase 3

Overview

The Urocross Expander System and Retrieval Sheath are investigational minimally invasive devices designed to treat LUTS due to BPH. The pivotal Expander‑2 trial has completed enrollment as of January 2025; results pending. No commercial approval yet.

Therapeutic areas: Men's Health
Modalities: DeviceNon-pharmacological therapy (minimally invasive implant-based procedure)
Industry: Surgical Medical Devices

Drug pipeline

1 asset

Urocross Expander System

Phase 3

Indications: Benign prostatic hyperplasia

Beyond the preview

Go deeper on Prodeon Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prodeon Medical.

Explore the full profile